Novocure Ltd.
(NASDAQ : NVCR)

( )
NVCR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -2.68%476.171.0%$548.85m
ABTAbbott Laboratories -2.03%106.380.8%$501.76m
DHRDanaher Corp. -3.18%232.150.7%$500.90m
MDTMedtronic Plc -2.53%102.550.6%$424.84m
ALGNAlign Technology, Inc. -3.42%439.516.4%$391.56m
ISRGIntuitive Surgical, Inc. -4.59%687.802.3%$360.97m
BSXBoston Scientific Corp. -5.47%34.081.0%$309.46m
DXCMDexCom, Inc. -8.28%349.127.9%$304.35m
BDXBecton, Dickinson & Co. -3.40%235.941.0%$257.61m
QDELQuidel Corp. -3.59%263.797.7%$236.84m
BAXBaxter International, Inc. -2.94%78.251.8%$195.30m
SYKStryker Corp. -4.05%204.811.3%$190.78m
VARVarian Medical Systems, Inc. -0.27%172.509.1%$187.36m
EWEdwards Lifesciences Corp. -4.25%73.250.4%$165.70m
IDXXIDEXX Laboratories, Inc. -4.57%422.893.8%$138.82m

Company Profile

NovoCure Ltd. develops treatment for tumors. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.